Singapore-headquartered telehealth firm ORA has raised $10 million in a Sequence A funding spherical – touted to be the most important telehealth funding in Southeast Asia so far – led by TNB Aura and Antler. The spherical was additionally participated by Gobi Companions, Kairous Capital, and GMA Ventures.
WHAT IT DOES
ORA runs a vertically-integrated telehealth platform that delivers over 250,000 consultations since launching in 2021. It homes three manufacturers: on-line dermatology model Modules, male health-focused andSons, and OVA, which is centred on feminine well being.
It’s set to launch its medically-backed merchandise throughout 1,300 tier-one shops later this 12 months.
WHAT IT’S FOR
The corporate presently operates in Singapore, Malaysia, and the Philippines, with plans to enter new territories utilizing its contemporary funds. In a press release, ORA mentioned it sees growth alternatives within the Center East. Furthermore, it’s eager to launch new choices quickly.
To this point, the corporate obtained $17 million in complete funding.
One other vertically-integrated telehealth platform in Singapore, Extraordinary Folks, additionally attracted investments final 12 months; it raised $5 million in pre-Sequence A funding for its growth throughout Singapore and Hong Kong.
Eucalyptus, an Australian firm that homes 5 telehealth manufacturers, additionally snapped up $42 million in Sequence C funding final 12 months for its growth in the UK.
ON THE RECORD
“ORA has had over six million affected person contact factors present us with helpful well being information by intensive well being evaluations and session on-line. This has introduced distinctive insights into these affected person’s healthcare expectations which have and can inform future improvements with our key companions,” mentioned CEO and founder Elias Pour, who was additionally Zalora’s ex-CMO.